Search Within

Maria Eugenia Arcila

Formats
  1. Meeting Abstract (391)
  2. Journal Article (247)
  3. Research Letter (12)
  4. Book Section (8)
  5. Review (7)
  6. Editorial (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Department of Pathology and Laboratory Medicine (670)
  2. Department of Medicine (458)
  3. GSK Faculty (456)
  4. Human Oncology and Pathogenesis Program (427)
  5. Tow Center for Developmental Oncology (TCDO) (346)
  6. Solid Tumor Oncology Division (317)

More Groups

People
  1. Marc Ladanyi (301)
  2. Michael Berger (163)
  3. Ahmet Zehir (126)
  4. Mark Kris (123)
  5. Khedoudja Nafa (108)
  6. Ryma Benayed (99)

More People

Years
  1. 2025 (11)
  2. 2024 (29)
  3. 2023 (43)
  4. 2022 (32)
  5. 2021 (37)
  6. 2020 (68)

More Years

Publications
  1. Journal of Molecular Diagnostics (93)
  2. Journal of Clinical Oncology (80)
  3. Laboratory Investigation (74)
  4. Modern Pathology (69)
  5. Blood (55)
  6. Clinical Cancer Research (36)

More Publications

Publishers
  1. Elsevier Science, Inc. (98)
  2. Nature Publishing Group (97)
  3. American Society of Clinical Oncology (96)
  4. Nature Research (69)
  5. American Association for Cancer Research (61)
  6. American Society of Hematology (61)

More Publishers

Results (670)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TERT promoter mutation and amplification: A pan-cancer study on 20,184 tumors profiled by clinical genomic sequencing
    Meeting Abstract

    Gupta, S.; Middha, S.; Benayed, R.; Arcila, M.; Zehir, A.; Berger, M. F.; Ladanyi, M.; Dogan, S.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Mining large panel hybrid capture-based clinical NGS data for novel virus pathogen-tumor associations based on mapping of off-target reads to viral genomes
    Meeting Abstract

    Vanderbilt, C. M.; Reichel, J.; Zehir, A.; Arcila, M.; Dogan, S.; Ladanyi, M.; Middha, S.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • PHF6 mutations define a subgroup of mixed phenotype acute leukemia with aberrant T-cell differentiation
    Meeting Abstract

    Lewis, N.; Pastore, F.; Kumar, P.; Getta, B.; Hultquist, A.; Shaffer, B.; Giralt, S.; Rampal, R.; Arcila, M.; Levine, R.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • t(14;18) negative inguinal follicular lymphoma is characterized by genetic abnormalities of 1p36/TNFRSF14 and 16p/CREBBP regions
    Meeting Abstract

    Khattar, P.; Pichardo, J. D.; Jelloul, F. Z.; Robert, C.; Areeyqur, R.; Rao, M.; Zhang, Y.; Arcila, M.; Wang, L.; Dogan, A.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Residual cytology material for the detection of targetable genetic alterations by next generation sequencing: An institutional experience
    Meeting Abstract

    Alex, D.; Nafa, K.; Middha, S.; Zehir, A.; Baldi, T.; Casanova, J.; Salazar, P. A.; Arcila, M.; Lin, O.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis analysis of data from the histology-independent, phase 2, open-label VE-BASKET study
    Journal Article

    Diamond, E. L.; Subbiah, V.; Lockhart, A. C.; Blay, J. Y.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J.; Erinjeri, J. P.; Torrisi, J.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Novel modification of HistoGel-based cell block preparation method: Improved sufficiency for molecular studies
    Journal Article

    Rekhtman, N.; Buonocore, D. J.; Rudomina, D.; Friedlander, M.; Dsouza, C.; Aggarwal, G.; Arcila, M.; Edelweiss, M.; Lin, O.
    Archives of Pathology & Laboratory Medicine (2018)

    Fulltext@MSK | Save
  • Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; more...
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients
    Journal Article

    Turner, S. R.; Buonocore, D.; Desmeules, P.; Rekhtman, N.; Dogan, S.; Lin, O.; Arcila, M. E.; Jones, D. R.; Huang, J.
    Lung Cancer (2018)

    Fulltext@MSK | Save